Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis-Reference-Cited by-同舟云学术

Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis

Published:2019-07-02 Issue:1 Volume:140 Page:16-26
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Lane Thirusha¹,Fontana Marianna¹,Martinez-Naharro Ana¹,Quarta Candida Cristina¹,Whelan Carol J.¹,Petrie Aviva¹,Rowczenio Dorota M.¹,Gilbertson Janet A.¹,Hutt David F.¹,Rezk Tamer¹,Strehina Svetla G.¹,Caringal-Galima Joan¹,Manwani Richa¹,Sharpley Faye A.¹,Wechalekar Ashutosh D.¹,Lachmann Helen J.¹,Mahmood Shameem¹,Sachchithanantham Sajitha¹,Drage Edmund P.S.²,Jenner Harvey D.²,McDonald Rosie²,Bertolli Ottavia²,Calleja Alan²,Hawkins Philip N.¹,Gillmore Julian D.¹

Affiliation:

1. National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).

2. Eastman Dental Institute, University College London, United Kingdom (A.P.). IQVIA, London, United Kingdom (E.P.S.D., H.D.J., R. McDonald, O.B., A.C.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Frequency and distribution of senile cardiovascular amyloid

2. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2‐macroglobulinandtau: A population‐based autopsy study

3. Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome

4. A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK

5. Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis

Cited by 330 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the Noninvasive Diagnostic Algorithm on Clinical Presentation and Prognosis in Cardiac Amyloidosis;JACC: Advances;2024-10

2. Changes of clinical characteristics, distribution of red flags and prognosis in contemporary patients with wild-type transthyretin amyloidosis cardiomyopathy;Annals of Medicine;2024-09-09

3. Effect of Timely Availability of TTR-Stabilizing Therapy on Diagnosis, Therapy, and Clinical Outcomes in ATTR-CM;Journal of Clinical Medicine;2024-09-06

4. Challenges in the approach to a patient with aortic stenosis and cardiac amyloidosis with ATTR mutation associated with negative scintigraphy - A case report;American Heart Journal Plus: Cardiology Research and Practice;2024-09

5. Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty;ESC Heart Failure;2024-08-21